News Focus
News Focus
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

Re: oc631 post# 1575

Wednesday, 02/09/2011 3:31:29 PM

Wednesday, February 09, 2011 3:31:29 PM

Post# of 20689

If the DOJ forced Teva to divest branded Copaxone to consummate the deal, there would be no shortage of bidders.

But such bids would be based on a generic-drug valuation model, rather than a branded-drug model, for the reasons mentioned earlier in this thread. Nobody would step in to offer a branded-drug valuation, and hence Teva would be crazy to divest branded Copaxone in such a transaction.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”